There is a little known company that is changing warfare

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

CLNN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 25.10%

Insider Buying (Last 12 Months): $535,890.25

Insider Selling (Last 12 Months): $17,535.00

Clene Insider Trading History Chart

Clene Share Price & Price History

^$4.53

▼ -0.16 (-3.41%)

As of 11/15/2024 01:00 AM ET

Days: 30 | 90 | 365

There is a little known company that is changing warfare

From Reticulate | Ad

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

Clene Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/30/2024	David J Matlin	Director	Buy	92,307	$4.75	$438,458.25	444,491
9/30/2024	Mark Mortenson	Insider	Buy	20,512	$4.75	$97,432.00	28,949
4/30/2024	General Resonance Llc	Major Shareholder	Sell	650	$8.40	$5,460.00	766,335
4/24/2024	General Resonance Llc	Major Shareholder	Sell	500	$6.60	$3,300.00	767,485
4/9/2024	General Resonance Llc	Major Shareholder	Sell	1,125	$7.80	$8,775.00	771,410
11/10/2023	David J Matlin	Director	Buy	12,500	$8.20	$102,500.00	352,184
6/26/2023	John Henry Stevens	Director	Buy	15,822	$16.00	$253,152.00	40,010
6/26/2023	Robert Dee Etherington	CEO	Buy	1,250	$16.20	$20,250.00	1,250
6/16/2023	David J Matlin	Director	Buy	75,000	$16.00	$1,200,000.00	339,684
11/2/2022	David J Matlin	Director	Buy	143,564	$20.20	$2,899,992.80	264,684
8/17/2022	John Henry Stevens	Director	Buy	2,383	$77.00	$183,491.00	16,761
7/18/2022	Robert Dee Etherington	CEO	Sell	1,174	$94.40	$110,825.60	2,829
6/17/2022	David J Matlin	Director	Buy	3,730	$50.20	$187,246.00	121,119
6/15/2022	Alison Mosca	Director	Buy	250	$52.40	$13,100.00	1,973
6/13/2022	David J Matlin	Director	Buy	2,750	$61.20	$168,300.00	108,838
6/6/2022	David J Matlin	Director	Buy	2,533	$51.40	$130,196.20	106,088
6/3/2022	David J Matlin	Director	Buy	500	$49.20	$24,600.00	103,555
5/27/2022	David J Matlin	Director	Buy	1,750	$45.40	$79,450.00	103,055
5/16/2022	General Resonance Llc	Major Shareholder	Sell	9,090	$44.00	$399,960.00	778,010
5/16/2022	Jonathon Gay	Director	Buy	500	$41.60	$20,800.00	3,437
5/16/2022	Robert Glanzman	Insider	Sell	235	$40.60	$9,541.00	528
4/20/2022	David J Matlin	Director	Buy	6,644	$60.20	$399,968.80	92,214
3/28/2022	David J Matlin	Director	Buy	500	$62.00	$31,000.00
3/23/2022	David J Matlin	Director	Buy	1,000	$58.80	$58,800.00
3/21/2022	David J Matlin	Director	Buy	1,750	$58.00	$101,500.00
3/18/2022	David J Matlin	Director	Buy	1,000	$55.80	$55,800.00
2/1/2022	David J Matlin	Director	Buy	5,067	$59.20	$299,966.40
12/10/2021	David J Matlin	Director	Buy	750	$97.40	$73,050.00
12/8/2021	David J Matlin	Director	Buy	250	$98.60	$24,650.00

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?

From Golden Crest | Ad

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide

SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)

23.28% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Clene Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/24/2024	Lunt Capital Management Inc.	29,540	$0.14M	0.1%	-95.0%	0.431%
10/21/2024	Castleview Partners LLC	12,783	$59K	0.0%	N/A	0.186%
7/10/2024	Csenge Advisory Group	269,600	$96K	0.0%	+131.2%	0.210%
1/26/2024	Soltis Investment Advisors LLC	109,517	$32K	0.0%	-50.0%	0.085%
11/15/2023	Worth Venture Partners LLC	1,404,284	$0.70M	0.4%	-5.3%	1.094%
11/15/2023	Kepos Capital LP	131,322	$65K	0.0%	-22.8%	0.102%
11/13/2023	Silverarc Capital Management LLC	500,000	$0.25M	0.1%	+100.0%	0.389%
11/13/2023	AIGH Capital Management LLC	5,801,878	$2.88M	1.4%	-2.3%	4.518%
11/8/2023	Vivo Capital LLC	2,645,338	$1.40M	0.2%	-41.5%	2.060%
11/1/2023	Csenge Advisory Group	116,600	$58K	0.0%	N/A	0.091%
10/11/2023	AE Wealth Management LLC	172,528	$86K	0.0%	+208.5%	0.134%
8/15/2023	Silverarc Capital Management LLC	250,000	$0.22M	0.1%	N/A	0.319%
8/11/2023	AWM Investment Company Inc.	5,000,000	$4.40M	0.6%	N/A	6.378%
7/17/2023	Impact Partnership Wealth LLC	55,928	$49K	0.0%	N/A	0.071%
7/10/2023	AE Wealth Management LLC	55,928	$49K	0.0%	N/A	0.071%
5/10/2023	Condor Capital Management	165,836	$0.19M	0.0%	N/A	0.214%
2/13/2023	Kepos Capital LP	344,427	$0.34M	0.0%	-13.9%	0.467%
11/15/2022	Tang Capital Management LLC	1,100,000	$3.08M	0.4%	N/A	1.490%
11/15/2022	Kepos Capital LP	400,000	$1.12M	0.1%	-33.3%	0.542%
10/21/2022	Morgan Jess S & Co. Inc.	112,000	$0.31M	0.3%	+28.4%	0.176%
8/12/2022	Ikarian Capital LLC	70,000	$0.18M	0.0%	-86.4%	0.111%
8/8/2022	Oppenheimer & Co. Inc.	32,026	$81K	0.0%	+27.2%	0.051%
5/16/2022	Morgan Jess S & Co. Inc.	87,250	$0.34M	0.3%	+193.3%	0.138%
5/11/2022	Veritable L.P.	20,000	$79K	0.0%	N/A	0.032%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	241,737	$0.95M	0.0%	-3.4%	0.382%
5/2/2022	Allspring Global Investments Holdings LLC	32,129	$0.13M	0.0%	N/A	0.051%
2/7/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	250,235	$1.11M	0.0%	N/A	0.402%
2/2/2022	Oppenheimer & Co. Inc.	22,214	$91K	0.0%	N/A	0.036%
11/15/2021	Penserra Capital Management LLC	5,154	$35K	0.0%	-35.9%	0.008%
11/12/2021	Laird Norton Trust Company LLC	268,581	$1.83M	0.2%	+7.6%	0.437%
11/12/2021	Geode Capital Management LLC	405,737	$2.77M	0.0%	+0.8%	0.660%
11/9/2021	Morgan Jess S & Co. Inc.	29,750	$0.20M	0.1%	N/A	0.048%
11/9/2021	BlackRock Inc.	1,065,726	$7.28M	0.0%	-9.5%	1.733%
11/9/2021	Soltis Investment Advisors LLC	218,920	$1.50M	0.2%	N/A	0.356%
11/4/2021	Deutsche Bank AG	11,284	$77K	0.0%	-16.9%	0.018%
11/2/2021	New York State Common Retirement Fund	12,560	$86K	0.0%	-35.9%	0.020%
8/17/2021	Boothbay Fund Management LLC	13,276	$0.15M	0.0%	-21.6%	0.022%
8/16/2021	California State Teachers Retirement System	31,590	$0.36M	0.0%	N/A	0.051%
8/16/2021	Pinz Capital Management LP	6,292	$71K	0.0%	N/A	0.010%
8/16/2021	Charles Schwab Investment Management Inc.	147,392	$1.66M	0.0%	+53.0%	0.240%
8/16/2021	State Street Corp	278,619	$3.13M	0.0%	N/A	0.453%
8/16/2021	Nuveen Asset Management LLC	54,870	$0.62M	0.0%	N/A	0.089%
8/13/2021	Northern Trust Corp	82,770	$0.93M	0.0%	+105.7%	0.135%
8/13/2021	Geode Capital Management LLC	402,395	$4.52M	0.0%	+82.6%	0.655%
8/13/2021	Vanguard Group Inc.	1,132,082	$12.73M	0.0%	+9.3%	1.844%
8/12/2021	Kepos Capital LP	550,000	$6.18M	0.5%	+175.0%	0.896%
8/12/2021	Penserra Capital Management LLC	8,043	$90K	0.0%	+37.7%	0.013%
8/12/2021	State of Wisconsin Investment Board	15,626	$0.18M	0.0%	N/A	0.025%
8/12/2021	Legal & General Group Plc	2,223	$25K	0.0%	N/A	0.004%
8/12/2021	JPMorgan Chase & Co.	8,785	$99K	0.0%	N/A	0.014%
8/12/2021	The Manufacturers Life Insurance Company	13,393	$0.15M	0.0%	N/A	0.022%
8/11/2021	Bank of New York Mellon Corp	57,228	$0.64M	0.0%	N/A	0.093%
8/11/2021	BlackRock Inc.	1,177,265	$13.23M	0.0%	+2,071.4%	1.918%
8/11/2021	Deutsche Bank AG	13,585	$0.15M	0.0%	N/A	0.022%
8/5/2021	Rhumbline Advisers	15,031	$0.17M	0.0%	N/A	0.024%
8/2/2021	New York State Common Retirement Fund	19,600	$0.22M	0.0%	N/A	0.032%
8/2/2021	SRS Capital Advisors Inc.	52,250	$0.59M	0.1%	N/A	0.085%
8/2/2021	Advisor Group Holdings Inc.	5,000	$56K	0.0%	N/A	0.008%
5/19/2021	Squarepoint Ops LLC	30,676	$0.39M	0.0%	N/A	0.051%
5/18/2021	Millennium Management LLC	130,068	$1.66M	0.0%	N/A	0.218%
5/18/2021	Citadel Advisors LLC	46,163	$0.59M	0.0%	N/A	0.077%
5/17/2021	Ikarian Capital LLC	118,533	$1.52M	0.1%	N/A	0.199%
5/17/2021	Goldman Sachs Group Inc.	13,593	$0.17M	0.0%	N/A	0.023%
5/13/2021	Laird Norton Trust Company LLC	249,561	$3.19M	0.4%	N/A	0.419%
5/13/2021	Penserra Capital Management LLC	5,840	$74K	0.0%	N/A	0.010%
5/13/2021	Kepos Capital LP	200,000	$2.56M	0.2%	-24.0%	0.336%
5/13/2021	Citigroup Inc.	10,646	$0.14M	0.0%	N/A	0.018%
5/12/2021	Northern Trust Corp	40,246	$0.51M	0.0%	N/A	0.068%
5/12/2021	Geode Capital Management LLC	220,355	$2.82M	0.0%	N/A	0.370%
5/7/2021	BlackRock Inc.	54,217	$0.69M	0.0%	N/A	0.091%
4/27/2021	Harel Insurance Investments & Financial Services Ltd.	34,911	$1.49M	0.0%	N/A	1.010%
2/16/2021	Walleye Trading LLC	15,909	$0.14M	0.0%	N/A	0.460%
2/12/2021	Basso Capital Management L.P.	3,239	$29K	0.0%	N/A	0.094%
2/12/2021	Kepos Capital LP	263,235	$2.37M	0.2%	N/A	7.617%
2/10/2021	Bluefin Capital Management LLC	15,378	$0.14M	0.0%	N/A	0.445%

Data available starting January 2016

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.

Today's Range

Now: $4.53

$4.34

$4.80

50 Day Range

MA: $5.43

$4.41

$6.74

52 Week Range

Now: $4.53

$3.82

$12.00

Volume

82,121 shs

Average Volume

70,798 shs

Market Capitalization

$31.06 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.42

Who are the company insiders with the largest holdings of Clene?: Clene's top insider shareholders include:
General Resonance Llc (Major Shareholder)
David J Matlin (Director)
John Henry Stevens (Director)
Mark Mortenson (Insider)
Robert Dee Etherington (CEO)
Learn More about top insider investors at Clene.
Who are the major institutional investors of Clene?: Clene's top institutional shareholders include:
Lunt Capital Management Inc. — 0.43%
Castleview Partners LLC — 0.19%
Learn More about top institutional investors of Clene stock.
Which institutional investors are selling Clene stock?: Within the last quarter, CLNN stock was sold by these institutional investors:
Lunt Capital Management Inc.
Which institutional investors are buying Clene stock?: During the last quarter, CLNN stock was acquired by institutional investors including:
Castleview Partners LLC
Within the previous year, these company insiders have bought Clene stock:
General Resonance Llc (Major Shareholder)
David J Matlin (Director)
John Henry Stevens (Director)
Mark Mortenson (Insider)
Learn More investors buying Clene stock.

There is a little known company that is changing warfare

From Reticulate | Ad

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

CLNN Insider Trading

Clene Insider Trading History Chart

Clene Share Price & Price History

Clene Insider Trading History

SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)

Institutional Buying and Selling by Quarter

Clene Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Clene?

Who are the major institutional investors of Clene?

Which institutional investors are selling Clene stock?

Which institutional investors are buying Clene stock?